Loading...

FITC anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7
C57BL/6 splenocytes stained with IM7 FITC
  • IM7
    C57BL/6 splenocytes stained with IM7 FITC
  • IM7_FITC_060710
    Human peripheral blood lymphocytes stained with IM7 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103021 25 tests 42 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103005 50 µg 47 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103006 500 µg 110 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103022 100 tests 112 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
µg sizes: 0.5 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References

(PubMed link indicates BioLegend citation)
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  2. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  3. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  4. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  5. Qu L, et al. 2022. Cell. 185:1728. PubMed
  6. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  7. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  8. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  9. Yang L, et al. 2023. JCI Insight. 8: . PubMed
  10. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  11. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  12. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  13. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  14. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  15. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  16. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  17. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  18. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  19. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  20. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  21. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  22. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  23. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  24. Israelow B, et al. 2020. bioRxiv. . PubMed
  25. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  26. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  27. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  28. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  29. Dong L, et al. 2021. Cancer Cell. . PubMed
  30. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  31. Wang D, et al. 2018. Immunity. 48:659. PubMed
  32. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  33. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  34. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  35. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  36. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  37. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  38. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  39. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  40. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  41. Diao L, et al. 2022. iScience. 25:105511. PubMed
  42. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  43. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  44. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  45. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  46. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  47. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  48. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  49. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  50. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  51. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  52. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  53. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  54. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  55. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  56. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  57. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  58. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  59. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  60. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  61. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  62. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  63. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  64. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  65. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  66. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  67. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  68. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  69. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  70. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  71. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  72. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  73. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  74. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  75. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  76. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  77. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  78. Wan X, et al. 2018. Nature. 560:107. PubMed
  79. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  80. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  81. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  82. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  83. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  84. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  85. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  86. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  87. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  88. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  89. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  90. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  91. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  92. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  93. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  94. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  95. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  96. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  97. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  98. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  99. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  100. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  101. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  102. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  103. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  104. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  105. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  106. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  107. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  108. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  109. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  110. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  111. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  112. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  113. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  114. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  115. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  116. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  117. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  118. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  119. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  120. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  121. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  122. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  123. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  124. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  125. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  126. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  127. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  128. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  129. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  130. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  131. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  132. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  133. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  134. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  135. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  136. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  137. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  138. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  139. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  140. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
  141. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  142. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
RRID
AB_493684 (BioLegend Cat. No. 103021)
AB_312956 (BioLegend Cat. No. 103005)
AB_312957 (BioLegend Cat. No. 103006)
AB_493685 (BioLegend Cat. No. 103022)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
PE anti-mouse/human CD44 IM7 FC
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
StarBright UltraViolet 795 anti-mouse/human CD44 IM7 FC
Spark YG™ 581 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark NIR™ 685 anti-mouse/human CD44 (Flexi-Fluor™) Antibody IM7 FC
Spark UV™ 387 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Go To Top Version: 2    Revision Date: 09.11.2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account